These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

157 related items for PubMed ID: 26271833

  • 21. Development and applications of universal H7 subtype-specific antibodies for the analysis of influenza H7N9 vaccines.
    Gravel C, Elmgren C, Muralidharan A, Hashem AM, Jaentschke B, Xu K, Widdison J, Arnold K, Farnsworth A, Rinfret A, Van Domselaar G, Wang J, Li C, Li X.
    Vaccine; 2015 Feb 25; 33(9):1129-34. PubMed ID: 25620245
    [Abstract] [Full Text] [Related]

  • 22. Selective Capture and Determination of Receptor-Binding Hemagglutinin in Influenza Vaccine Preparations Using a Coupled Receptor-Binding/RP-HPLC Assay.
    Lorbetskie B, Cunningham AM, Lemieux M, Durno L, Farnsworth A, Wang J, Li C, Li X, Gilbert M, Sauvé S, Girard M.
    Anal Chem; 2019 Jul 16; 91(14):8908-8917. PubMed ID: 31251585
    [Abstract] [Full Text] [Related]

  • 23. Application of recombinant hemagglutinin proteins as alternative antigen standards for pandemic influenza vaccines.
    Choi Y, Kwon SY, Oh HJ, Shim S, Chang S, Chung HJ, Kim DK, Park Y, Lee Y.
    Biotechnol Lett; 2017 Sep 16; 39(9):1375-1380. PubMed ID: 28612264
    [Abstract] [Full Text] [Related]

  • 24. A monoclonal antibody-based immunoassay for measuring the potency of 2009 pandemic influenza H1N1 vaccines.
    Schmeisser F, Vasudevan A, Soto J, Kumar A, Williams O, Weir JP.
    Influenza Other Respir Viruses; 2014 Sep 16; 8(5):587-95. PubMed ID: 25087462
    [Abstract] [Full Text] [Related]

  • 25. Influenza virus-like particle can accommodate multiple subtypes of hemagglutinin and protect from multiple influenza types and subtypes.
    Pushko P, Pearce MB, Ahmad A, Tretyakova I, Smith G, Belser JA, Tumpey TM.
    Vaccine; 2011 Aug 11; 29(35):5911-8. PubMed ID: 21723354
    [Abstract] [Full Text] [Related]

  • 26. Development and fit-for-purpose verification of an LC-MS method for quantitation of hemagglutinin and neuraminidase proteins in influenza virus-like particle vaccine candidates.
    Guo J, Lu Y, Zhang Y, Mugabe S, Wei Z, Borisov OV.
    Anal Biochem; 2020 Mar 01; 592():113577. PubMed ID: 31926146
    [Abstract] [Full Text] [Related]

  • 27. Flagellin-HA vaccines protect ferrets and mice against H5N1 highly pathogenic avian influenza virus (HPAIV) infections.
    Liu G, Song L, Reiserova L, Trivedi U, Li H, Liu X, Noah D, Hou F, Weaver B, Tussey L.
    Vaccine; 2012 Nov 06; 30(48):6833-8. PubMed ID: 23000130
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Induction of broadly neutralizing H1N1 influenza antibodies by vaccination.
    Wei CJ, Boyington JC, McTamney PM, Kong WP, Pearce MB, Xu L, Andersen H, Rao S, Tumpey TM, Yang ZY, Nabel GJ.
    Science; 2010 Aug 27; 329(5995):1060-4. PubMed ID: 20647428
    [Abstract] [Full Text] [Related]

  • 30. Determination of the potency of a cell-based seasonal quadrivalent influenza vaccine using a purified primary liquid standard.
    Takahashi H, Fujimoto T, Horikoshi F, Uotani T, Okutani M, Shimasaki N, Hamamoto I, Odagiri T, Nobusawa E.
    Biologicals; 2020 Nov 27; 68():32-39. PubMed ID: 33023810
    [Abstract] [Full Text] [Related]

  • 31. Influenza virus-like particles elicit broader immune responses than whole virion inactivated influenza virus or recombinant hemagglutinin.
    Bright RA, Carter DM, Daniluk S, Toapanta FR, Ahmad A, Gavrilov V, Massare M, Pushko P, Mytle N, Rowe T, Smith G, Ross TM.
    Vaccine; 2007 May 10; 25(19):3871-8. PubMed ID: 17337102
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Distinct contributions of vaccine-induced immunoglobulin G1 (IgG1) and IgG2a antibodies to protective immunity against influenza.
    Huber VC, McKeon RM, Brackin MN, Miller LA, Keating R, Brown SA, Makarova N, Perez DR, Macdonald GH, McCullers JA.
    Clin Vaccine Immunol; 2006 Sep 10; 13(9):981-90. PubMed ID: 16960108
    [Abstract] [Full Text] [Related]

  • 35. The highly conserved HA2 protein of the influenza A virus induces a cross protective immune response.
    Lee JS, Chowdhury MY, Moon HJ, Choi YK, Talactac MR, Kim JH, Park ME, Son HY, Shin KS, Kim CJ.
    J Virol Methods; 2013 Dec 10; 194(1-2):280-8. PubMed ID: 24004822
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Generation of monoclonal pan-hemagglutinin antibodies for the quantification of multiple strains of influenza.
    Manceur AP, Zou W, Marcil A, Paquet E, Gadoury C, Jaentschke B, Li X, Petiot E, Durocher Y, Baardsnes J, Rosa-Calatrava M, Ansorge S, Kamen AA.
    PLoS One; 2017 Dec 10; 12(6):e0180314. PubMed ID: 28662134
    [Abstract] [Full Text] [Related]

  • 38. The differential effect of sub-micron level HA aggregates on influenza potency assays.
    Lemieux M, Lorbetskie B, Luebbert CC, Walrond L, Li C, Li X, Cyr T, Sauvé S, Johnston MJW, Farnsworth A.
    Vaccine; 2019 Aug 23; 37(36):5276-5287. PubMed ID: 31337591
    [Abstract] [Full Text] [Related]

  • 39. Influenza bivalent vaccine comprising recombinant H3 hemagglutinin (HA) and H1 HA containing replaced H3 hemagglutinin transmembrane domain exhibited improved heterosubtypic protection immunity in mice.
    Liu Q, Xue C, Zheng J, Liu K, Wang Y, Wei Y, Liu GD, Cao Y.
    Vaccine; 2015 Jul 31; 33(32):4035-40. PubMed ID: 26100927
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.